Alphagan p and Lutein drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan p (brimonidine tartrate) and Lutein (lutein). Common drug interactions include fall among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan p and Lutein. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan p?

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 6,579 Alphagan p users. Check the latest studies of Alphagan p.

What is Lutein?

Lutein has active ingredients of lutein. It is often used in macular degeneration. eHealthMe is studying from 7,461 Lutein users. Check the latest studies of Lutein.

On Jul, 12, 2026

29 people who take Alphagan p and Lutein together, and have interactions are studied.

Alphagan p and Lutein drug interactions.

What are the common drug interactions of Alphagan P and Lutein, by gender? *:

female:

Fall
Pruritus (severe itching of the skin)
Ear pain
Herpes zoster
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Infusion site mass
Infusion site pruritus (severe itching at infusion site)
Limb injury
Multiple allergies (allergy to multiple agents)
Pyrexia (fever)

male:

Pneumonia
Asthenia (weakness)
Malaise (a feeling of general discomfort or uneasiness)
Peripheral swelling
Pleural effusion (water on the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sinusitis (inflammation of sinus)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)

What are the common drug interactions of Alphagan P and Lutein, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Malaise (a feeling of general discomfort or uneasiness)
Dyspnoea (difficult or laboured respiration)
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Pleural effusion (water on the lungs)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sinusitis (inflammation of sinus)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 17.24%
Immunodeficiency Common Variable: 4 people, 13.79%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 10.34%
Multiple Myeloma (cancer of the plasma cells): 3 people, 10.34%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 6.90%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 6.90%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 6.90%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 2 people, 6.90%
Pain: 2 people, 6.90%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan p and Lutein?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously